You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 11, November 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE AMERICAN SOCIETY FOR HEAD AND NECK SURGERY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Treatment of Recurrent Pleomorphic Adenoma of the Parotid Gland

John K. Niparko, MD; Mark L. Beauchamp, MD; Charles J. Krause, MD; Shan R. Baker, MD; Walter P. Work, MD

Arch Otolaryngol Head Neck Surg. 1986;112(11):1180-1184.


Abstract

• Recurrent pleomorphic adenomas of the parotid gland warrant consideration because of the potential for facial nerve injury occurring with surgical treatment and the risk of malignant conversion. Forty-eight cases of recurrent pleomorphic adenoma treated at the University of Michigan, Ann Arbor, between 1935 and 1975 were retrospectively analyzed. The results of surgical procedures for recurrence were determined with respect to tumor control and resultant facial nerve function. Malignant conversion developed in three (6%) of 48 cases. The results of this study underscore the importance of adequate surgical excision of initial recurrences as well as primary tumors to prevent tumor recidivism. Tumor control rates and facial nerve preservation are enhanced with formal parotidectomy for recurrent tumor when feasible. In cases in which facial nerve identification and dissection is not possible, en bloc total parotidectomy offers effective, though not absolute, control of extensive recurrence.

(Arch Otolaryngol Head Neck Surg 1986;112:1180-1184)



Author Affiliations

From the Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor (Drs Niparko, Beauchamp, Krause, and Baker), and the Section of Otolaryngology-Head and Neck Surgery, University of Arizona, Tucson (Dr Work).


Footnotes

Accepted for publication June 17, 1986.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 8, 1986.

Reprint requests to the Department of Otolaryngology-Head and Neck Surgery, 1500 E Medical Center Dr, Box 0321, Ann Arbor, MI 48109-0312 (Dr Krause).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Imaging Characteristics of Recurrent Pleomorphic Adenoma of the Parotid Gland
Moonis et al.
Am. J. Neuroradiol. 2007;28:1532-1536.
ABSTRACT | FULL TEXT  

Clinical Outcome of Continuous Facial Nerve Monitoring During Primary Parotidectomy
Terrell et al.
Arch Otolaryngol Head Neck Surg 1997;123:1081-1087.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.